Related references
Note: Only part of the references are listed.The role of oclacitinib in the management of ischaemic dermatopathy in four dogs
Britt J. Levy et al.
VETERINARY DERMATOLOGY (2019)
Demonstration of rebound phenomenon following abrupt withdrawal of the JAK1 inhibitor oclacitinib
Tomoki Fukuyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
Andrea J. Gonzales et al.
VETERINARY DERMATOLOGY (2016)
Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study
Ana M. Lourenco et al.
VETERINARY DERMATOLOGY (2016)
Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)
Thierry Olivry et al.
BMC VETERINARY RESEARCH (2015)
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life
Sallie B. Cosgrove et al.
VETERINARY DERMATOLOGY (2015)
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
Peter R. Little et al.
VETERINARY DERMATOLOGY (2015)
Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
A. J. Gonzales et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2014)
Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs
Thierry Olivry et al.
VETERINARY DERMATOLOGY (2014)
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia
Caroline Gadeyne et al.
VETERINARY DERMATOLOGY (2014)
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis
Sallie B. Cosgrove et al.
VETERINARY DERMATOLOGY (2013)
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis
Sallie B. Cosgrove et al.
VETERINARY DERMATOLOGY (2013)
Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis
Andrea J. Gonzales et al.
VETERINARY DERMATOLOGY (2013)
Current understanding of the pathophysiologic mechanisms of canine atopic dermatitis
Rosanna Marsella et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2012)
Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis
Tim J. Nuttall et al.
VETERINARY DERMATOLOGY (2012)
A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis
Claude Favrot et al.
VETERINARY DERMATOLOGY (2010)
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis
Thierry Olivry et al.
VETERINARY DERMATOLOGY (2010)
Further validation of a pruritus severity scale for use in dogs
J. Rybnicek et al.
VETERINARY DERMATOLOGY (2009)
Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial
Tim Nuttall et al.
VETERINARY DERMATOLOGY (2009)
Development of an owner-assessed scale to measure the severity of pruritus in dogs
P. B. Hill et al.
VETERINARY DERMATOLOGY (2007)
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients
Dirk Jan Hijnen et al.
DERMATITIS (2007)
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis
K Breuer et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2005)
The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy
T Olivry et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2001)
The ACVD task force on canine atopic dermatitis (II): genetic factors
CA Sousa et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2001)
Share Paper
